Trial
NCT02758067
Comparison of the Effectiveness of Brexpiprazole With That of Risperidone
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
H. Lundbeck A/S
Collaborators
Otsuka Pharmaceutical Co., Ltd.
Condition
Schizophrenia
Intervention
brexpiprazole
Why stopped
This study was withdrawn for administrative reasons. There were no safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-01